Preprint · CC-BY
via bioRxiv
Characterization of Pro-Fibrotic Signaling Pathways using Human Hepatic Organoids
Guan, Y., Fang, Z., Hu, A., Roberts, S., Wang, M., Ren, W., Johansson, P. K., Heilshorn, S. C., Enejder, A., Peltz, G.
biorxiv · 2024
Abstract
Due to the limitations of available in vitro systems and animal models, we lack a detailed understanding of the pathogenetic mechanisms and have minimal treatment options for liver fibrosis. To overcome this barrier, we engineered a live cell imaging system that identifies collagen producing cells in a human multi-lineage hepatic organoid. This system was adapted for use as a microwell-based platform (i.e., microHOs) where exposure to PDGF or TGF{beta}1 induced the formation of thick collagen fibers. Transcriptomic analysis revealed that TGF{beta}1 exposure converted mesenchymal cells into myofibroblast-like cells that contribute to the development of liver fibrosis. When pro-fibrotic intracellular signaling pathways were examined using pharmacological probes, the anti-fibrotic effect of receptor-specific tyrosine kinase inhibitors was limited to the fibrosis induced by the corresponding growth factor, which indicates that their anti-fibrotic efficacy would be limited to fibrotic diseases that were solely mediated by that growth factor. Transcriptomic and transcription factor activation analyses were used to identify pathways that were jointly activated by PDGF and TGF{beta}1. GSK3{beta} or p38 MAPK inhibitors could prevent TGF{beta}1- or PDGF-induced fibrosis in microHOs because they block intracellular signaling pathways that are commonly utilized by the TGF{beta}1 and PDGF receptors. Hence, these studies identified GSK3{beta} and p38 MAPK inhibitors as potential new broad-spectrum therapies for liver fibrosis, and it is likely that other new therapies could subsequently be identified using this microHO system.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- bioRxiv
- DOI
- 10.1101/2023.04.25.538102
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Y., G., Z., F., A., H., S., R., M., W., W., R., K., J.P., C., H.S., A., E., & G., P. (2024). Characterization of Pro-Fibrotic Signaling Pathways using Human Hepatic Organoids. <em>biorxiv</em>. https://doi.org/10.1101/2023.04.25.538102
Vancouver
Y. G, Z. F, A. H, S. R, M. W, W. R, et al. Characterization of Pro-Fibrotic Signaling Pathways using Human Hepatic Organoids. biorxiv. 2024. doi:10.1101/2023.04.25.538102.
BibTeX
@unpublished{guan2024Charac,
title = {Characterization of Pro-Fibrotic Signaling Pathways using Human Hepatic Organoids},
author = {Guan, Y. and Fang, Z. and Hu, A. and Roberts, S. and Wang, M. and Ren, W. and Johansson, P. K. and Heilshorn, S. C. and Enejder, A. and Peltz, G.},
journal = {biorxiv},
year = {2024},
doi = {10.1101/2023.04.25.538102},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Immunology 2020
Open access · CC-BY
Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage
Pharmaceutics 2021
Open access · CC-BY
Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease
In Vitro Cellular & Developmental Biology - Animal 2023
Open access · CC-BY
Ecliptasaponin A attenuates renal fibrosis by regulating the extracellular matrix of renal tubular cells
American Journal of Physiology-Renal Physiology 2000
Citation only
Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine
Journal of Biological Chemistry 2022
Open access · CC-BY
Histone deacetylase-10 liberates spermidine to support polyamine homeostasis and tumor cell growth
Journal of the American Society of Nephrology 2014
Preprint · OA